期刊文献+

人子宫颈病变组织中P53表达及其与端粒酶hTR mRNA的关系 被引量:2

The expression of P53 protein in human cervical lesion tissues and its relationship with telomerase hTR mRNA
原文传递
导出
摘要 目的:探讨人子宫颈病变组织中P53的表达及其与端粒酶hTR mRNA表达的相关关系。方法:51例宫颈病变组织中,包括宫颈炎10例,LSIL10例,HSIL20例,SCC11例,分别利用免疫组化S-P法和原位杂交法检测病变组织中P53蛋白、端粒酶hTRmRNA的表达活性。结果:P53表达在宫颈炎组与LSIL组无差别,但显著低于HSIL和SCC组;hTR基因在HSIL/SCC中的阳性表达与CC/LSIL组以及在LSIL和HSIL/SCC之间差异有统计学意义(P<0.05);P53蛋白表达与端粒酶hTRmRNA基因表达之间具有显著相关性(P=0.042,P<0.05)。结论:端粒酶hTR和P53蛋白表达及相关性对于人子宫颈癌的早期病理诊断有较好地应用价值。同时,对该肿瘤的发生、发展规律提供一定的客观依据。 Objective:To explore the expression of P53 protein in human cervical lesion tissues and its relationship with telomerase hTR mRNA.Methods:51 samples of cervical lesion tissues were selected,including 10 samples of cervicitis,10 samples of low grade squamous intraepithelial lesion(LSIL),20 samples of high grade squamous intraepithelial lesion(HSIL) and 11 samples of squamous cell carcinoma(SCC);immunohistochemical SP method and in situ hybridization were used to detect the expression levels of P53 protein and telomerase hTR mRNA.Results:There was no significant difference in expression level of P53 protein between cervicitis group and LSIL group,but the expression levels of P53 protein in cervicitis group and LSIL group were significantly lower than those in HSIL group and SCC group;there was significant difference in expression level of telomerase hTR mRNA between HSIL/SCC group and cervicitis/LSIL group,as well as between LSIL group and HSIL/SCC group(P〈0.05).There was a significant correlation between P53 protein expression and telomerase hTR mRNA expression(P=0.042,P〈0.05).Conclusion:Telomerase hTR mRNA expression and P53 protein expression and their correlation are of great application value in early pathological diagnosis,which provide a certain objective basis for the oncogenesis and development of cervical carcinoma.
出处 《中国妇幼保健》 CAS 北大核心 2011年第10期1539-1542,共4页 Maternal and Child Health Care of China
基金 深圳市科技计划项目〔200204068 200802033〕
关键词 子宫颈 P53 人端粒酶RNA组分 端粒酶 Cervix; P53 protein; Human telomerase RNA; Telomerase;
  • 相关文献

参考文献10

二级参考文献44

  • 1张东升,卞翠荣,王佩玉,袁锡兰,王家耀.唾液腺腺样囊性癌p53基因突变及其与临床病理的关系[J].上海口腔医学,2004,13(5):396-398. 被引量:3
  • 2王洁,董福生,顾洪涛,李荷香,董青.涎腺腺样囊性癌细胞凋亡的诱导与P53基因的修复[J].现代口腔医学杂志,2004,18(6):492-495. 被引量:3
  • 3Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers. Science, 1991,253:49-53.
  • 4Karja VJ, Syrjanen KJ, Kurvinen AK, et al. Expression and mutations of p53 in salivary gland tumours. J Oral Pathol Med,1997,26:217-223.
  • 5Liao J , Mitsuyasu T , Yamane K, et al. Telomerase activity in oral and maxillofacial tumors. Oral Oncol, 2000,36:347-352.
  • 6Alves FA, Pires FR, De Almeida OP, et al. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours. Int J Oral Maxillofac Surg,2004 ,33 :593-597.
  • 7Nakayama J, Tahara H, Tahara E, et al. Telomerase activation by hTERT in human normal fibroblasts and hepatoecllular carcinomas.Nat Genet, 1998,18:65-68.
  • 8Lebedeva S , Bagdasarova S , Tyler T , et al. Tumor suppression and therapy sensitization of localized and metastatic breast cancer by adenovirus p53. Hum OeneTher,2001,12 :763-772.
  • 9Seki M, Iwakawa J , Cheng H , et al. p53 and PTEN/MMAC1/TEP1 gene therapy of human prostate PC-3 carcinoma xenograft,using transfemin- facilitated-lipofection gene delivery strategy. Hum Gene Ther,2002 ,13 :761-773.
  • 10Kanaya T, Kyo S, Hamada K, et al. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin Cancer Res,2000,6 : 1239-1247.

共引文献37

同被引文献29

  • 1Crum CP, Egawa K, Fu YS, et al. Atypical immature metaplasia (AIM) :a subset of human papilloma virus infection of the cervix [ J]. Cancer, 1983,51(12) :2214-2219.
  • 2Nagakubo D,Taira T, Kitaura H, et al. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras [ J ]. Biochem Biophys Res Commun, 1997,231 ( 2 ) : 509 - 513.
  • 3MacKeigan JP, Clements CM, Lich JD, et al. Proteomic profiling drug-induced apoptosis in non-smaU cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha [ J ]. Cancer Res, 2003,63(20) : 6928 -6934.
  • 4Davidson B, Hadar R, Schlossberg A, et al. Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma [ J ]. Hum Pathol,2008,39 ( 1 ) : 87 - 95.
  • 5Zhang HY, Wang HQ, Liu HM, et al. Regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by DJ-1 in thyroid cancer cells [ J ]. Endocr Relat Cancer,2008,15 (2) :535 - 544.
  • 6Tillman JE, Yuan J, Gu G, et al. D J-1 binds androgen receptor directly and mediates its activity in hormonally treated prostatecancer cells [ J ]. Cancer Res,2007, 67 ( 10 ) :4630 - 4637.
  • 7Duggan MA, Akbari M, Magliocco AM. Atypical immature cervical metaplasia: immunoprofiling and longitudinal outcome [J]. Hum Pathol, 2006,37(11):1473 -1481.
  • 8Miyatake T, Ueda Y, Yoshino K, et al. Clonality analysis and human papillomavirus infection in squamous metaplasia and atypical immature metaplasia of uterine cervix: is atypical immature metaplasia a precursor to cervical intraepithelial neoplasia 3 [ J] ? Int J Gynecol Pathol,2007,26(2) :180 - 187.
  • 9I-Iong Z, Shi M, Chung KA, et al. D J-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease [J]. Brain,2010,133 (3) : 713 -726.
  • 10Yuen HF, Chan YP, Law S, et al. DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma [ J ]. Cancer Epidemiol Biomarkers Prey,2008,17 (12) : 3593 - 3602.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部